- Home
- KUST vs CLDI Comparison
KUST vs CLDI Comparison
Compare KUST & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KUST | CLDI |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4M | 2.4M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | KUST | CLDI |
|---|---|---|
| Price | $3.67 | $0.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 16.9K | ★ 64.3K |
| Earning Date | 11-11-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,577,600.00 | $45,000.00 |
| Revenue This Year | $40.06 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.55 | $0.09 |
| 52 Week High | $224.00 | $3.38 |
Technical Indicators
Market Signals| Indicator | KUST | CLDI |
|---|---|---|
| Relative Strength Index (RSI) | 44.41 | 24.62 |
| Support Level | N/A | $0.40 |
| Resistance Level | $17.87 | $1.29 |
| Average True Range (ATR) | 1.24 | 0.06 |
| MACD | -0.87 | -0.02 |
| Stochastic Oscillator | 0.17 | 3.74 |
Price Performance
Historical ComparisonAbout KUST Kustom Entertainment Inc. Common Stock
Kustom Entertainment Inc provides live event production and ticketing technology services. The company operates in two segments: video solutions and entertainment. The Video Solutions Segment represents the Company's legacy operations and includes the development, manufacture, and sale of digital video imaging and storage products, disinfectant, and related safety products for use in law enforcement, security, and commercial applications. The Entertainment Segment operates a secondary ticketing platform through TicketSmarter.com, acting as an intermediary between ticket buyers and sellers. In addition, this segment includes live event production and promotion activities, including the Country Stampede music festival and other entertainment events.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. Its technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent genetic medicine(s) to metastatic locations. Its product candidates include The RedTail for Metastatic Solid Tumors, CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-101 (NeuroNova) for Newly Diagnosed High Grade Glioma.